Wedbush Downgrades Cross Country Healthcare to Neutral, Lowers Price Target to $13.25
Cross Country Healthcare, Inc.
Cross Country Healthcare, Inc. CCRN | 0.00 |
Wedbush analyst Michael Piccolo downgrades Cross Country Healthcare (NASDAQ:
CCRN) from Outperform to Neutral and lowers the price target from $15 to $13.25.
